Q1 2018 Holdings
Filed 2018-05-15 | 53 holdings | $37.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $12.1M | 150,000 | 32.0% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $9.2M | 140,000 | 24.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $9.0M | 400,000 | 23.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $5.8M | 800,000 | 15.3% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $1.3M | 550,000 | 3.5% |
| Incyte Corp(INCY)Put | COM | 45337C102 | $83.3K | 8,333 | 0.2% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $35.1K | 8,773 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $27.0K | 1,850,000 | 0.1% |
| Endocyte Inc | COM | 29269A102 | $20.0K | 2,200,000 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $17.4K | 235,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $16.9K | 1,000,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $16.7K | 135,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $15.9K | 850,000 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $14.4K | 350,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $14.2K | 550,000 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $11.6K | 450,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $11.3K | 750,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $11.0K | 120,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $9.1K | 950,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $9.1K | 500,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $8.1K | 262,500 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $8.0K | 350,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $7.8K | 325,000 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $7.6K | 45,000 | 0.0% |
| Assembly Biosciences Inc | COM | 045396108 | $7.4K | 150,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $7.0K | 314,367 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $6.8K | 1,600,000 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $6.2K | 850,000 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $5.8K | 900,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $5.6K | 400,000 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $5.6K | 150,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $5.4K | 200,000 | 0.0% |
| Obseva SA | COM | H5861P103 | $5.4K | 400,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $5.0K | 600,000 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $4.7K | 500,000 | 0.0% |
| Currencyshares Swiss Franc T | SWISS FRANC SH | 23129V109 | $4.5K | 45,800 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $4.4K | 278,244 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $4.3K | 300,000 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $4.1K | 250,000 | 0.0% |
| Lannet Inc | COM | 516012101 | $4.0K | 250,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $4.0K | 75,000 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $3.7K | 1,750,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $3.5K | 61,900 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $2.9K | 385,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $2.8K | 125,092 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $2.3K | 100,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN)Call | COM | G11196105 | $1.9K | 75,100 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $1.8K | 11,100 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.0K | 76,786 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $1.0K | 200,000 | 0.0% |